Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gourlet

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Biochimica Et Biophysica Acta|December 12, 1996
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptorsP Gourlet, A Vandermeers, M C Vandermeers-Piret, et al.
Regulatory Peptides|April 23, 1996
C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptorsP Gourlet, A Vandermeers, M C Vandermeers-Piret, et al.
The American Journal of Physiology|January 1, 1991
PACAP and VIP receptors in rat liver membranesP Robberecht, P Gourlet, A Cauvin, et al.
European Journal of Pharmacology|December 4, 1995
Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptorsP Gourlet, A Vandermeers, M C Vandermeers-Piret, et al.
Digestion|January 1, 1990
VIP receptors in human SUP-T1 lymphoblastsJ Christophe, A Cauvin, E Vervisch, et al.
European Journal of Biochemistry|July 15, 1996
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptorP Gourlet, J P Vilardaga, P De Neef, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptorsP Gourlet, A Vandermeers, J Van Rampelbergh, et al.
Peptides|January 1, 1997
Development of high affinity selective VIP1 receptor agonistsP Gourlet, A Vandermeers, P Vertongen, et al.
European Journal of Pharmacology|July 3, 1998
Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypesP Gourlet, M C Vandermeers-Piret, J Rathé, et al.
Molecular Pharmacology|November 26, 1999
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligandsM G Juarranz, J Van Rampelbergh, P Gourlet, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Biochimica Et Biophysica Acta|December 12, 1996
Effect of introduction of an arginine16 in VIP, PACAP and secretin on ligand affinity for the receptorsP Gourlet, A Vandermeers, M C Vandermeers-Piret, et al.
Regulatory Peptides|April 23, 1996
C-terminally shortened pituitary adenylate cyclase-activating peptides (PACAP) discriminate PACAP I, PACAP II-VIP1 and PACAP II-VIP2 recombinant receptorsP Gourlet, A Vandermeers, M C Vandermeers-Piret, et al.
The American Journal of Physiology|January 1, 1991
PACAP and VIP receptors in rat liver membranesP Robberecht, P Gourlet, A Cauvin, et al.
European Journal of Pharmacology|December 4, 1995
Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptorsP Gourlet, A Vandermeers, M C Vandermeers-Piret, et al.
Digestion|January 1, 1990
VIP receptors in human SUP-T1 lymphoblastsJ Christophe, A Cauvin, E Vervisch, et al.
European Journal of Biochemistry|July 15, 1996
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptorP Gourlet, J P Vilardaga, P De Neef, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Analogues of VIP, helodermin, and PACAP discriminate between rat and human VIP1 and VIP2 receptorsP Gourlet, A Vandermeers, J Van Rampelbergh, et al.
Peptides|January 1, 1997
Development of high affinity selective VIP1 receptor agonistsP Gourlet, A Vandermeers, P Vertongen, et al.
European Journal of Pharmacology|July 3, 1998
Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypesP Gourlet, M C Vandermeers-Piret, J Rathé, et al.
Molecular Pharmacology|November 26, 1999
Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligandsM G Juarranz, J Van Rampelbergh, P Gourlet, et al.
Pageof 5